Strategic Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$510K Hold
908
0.02% 100
2025
Q4
$585K Hold
908
0.03% 89
2025
Q3
$580K Hold
908
0.03% 86
2025
Q2
$487K Hold
908
0.03% 94
2025
Q1
$381K Hold
908
0.02% 100
2024
Q4
$375K Hold
908
0.02% 104
2024
Q3
$459K Hold
908
0.03% 94
2024
Q2
$442K Hold
908
0.03% 95
2024
Q1
$490K Hold
908
0.03% 82
2023
Q4
$504K Sell
908
-20
-2% -$9.39K 0.04% 86
2023
Q3
$406K Hold
928
0.03% 95
2023
Q2
$481K Hold
928
0.04% 90
2023
Q1
$464K Hold
928
0.04% 88
2022
Q4
$379K Hold
928
0.03% 94
2022
Q3
$302K Hold
928
0.03% 103
2022
Q2
$325K Hold
928
0.03% 103
2022
Q1
$508K Hold
928
0.04% 91
2021
Q4
$611K Buy
+928
New +$583K 0.05% 91

Other funds holding IDXX

Strategic Financial Services's IDXX Position: Q1 2026 in Review

Strategic Financial Services held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 908 shares worth $510K. The position accounts for 0.02% of the portfolio, ranked #100.

Strategic Financial Services first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $611K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Strategic Financial Services held 908 shares of Idexx Laboratories worth $510K as of Q1 2026.
  • Strategic Financial Services left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.02% of Strategic Financial Services's portfolio in Q1 2026, its #100 holding.
  • Strategic Financial Services first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • Strategic Financial Services's Idexx Laboratories position peaked at $611K in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Strategic Financial Services's 13F filing for Q1 2026, filed 8 May 2026.